Literature DB >> 24061638

Antiapoptotic gene BAG-1 vector structure of RNA interference and endogenous targeted screening in colon cancer cell lines.

Nian-feng Sun1, Ai-ling Tian, Zhan-ao Liu, San-yuan Hu, An-bin Hu.   

Abstract

The purposes of the present work were to construct the shRNA plasmids for BAG-1 gene of human and test the expression of mRNA and protein of BAG-1. Recombinant plasmids containing green fluorescent protein reporter genes are constructed using gene cloning methods. The shRNA plasmids for the BAG-1 gene are constructed by RNA interference technology. We applied fluorescent plasmid-transfected target cells in the cell transfection experiments and monitored the transfection rate of plasmids by observing the fluorescence amount. We transfected three synthesized shRNA in target screening cell and adopted RT-PCR and Western test to identify the difference of target gene transfection and translation level in cells. The specific shRNA plasmid for the BAG-1 gene was successfully recombined, and stably transfected colon cancer Lo Vo cell lines were obtained. The results present that the constructed shRNA plasmids significantly inhibited the expression of mRNA and protein of Lo Vo cell BAG-1, and can maintain the effect for a long term. pGPH1/GFP/Neo-BAG-1-homo-825 was screened as the optimum sequence of interference so as to lay a solid foundation to explore into the research on the BAG-1 gene and the biological behavior of colon cancer cells. It showed the remarkable advantage of RNAi in the generation of posttranscriptional gene silencing.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24061638     DOI: 10.1007/s13277-013-1140-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  12 in total

Review 1.  The silent revolution: RNA interference as basic biology, research tool, and therapeutic.

Authors:  Derek M Dykxhoorn; Judy Lieberman
Journal:  Annu Rev Med       Date:  2005       Impact factor: 13.739

2.  Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide.

Authors:  Maria Lindgren; Katri Rosenthal-Aizman; Külliki Saar; Emelía Eiríksdóttir; Yang Jiang; Meeri Sassian; Pernilla Ostlund; Mattias Hällbrink; Ulo Langel
Journal:  Biochem Pharmacol       Date:  2006-01-10       Impact factor: 5.858

Review 3.  From chemotherapy to targeted therapy in adjuvant treatment for stage III colon cancer.

Authors:  Aimery de Gramont; Armand de Gramont; Benoist Chibaudel; Jean-Baptiste Bachet; Annette K Larsen; Christophe Tournigand; Christophe Louvet; Thierry André
Journal:  Semin Oncol       Date:  2011-08       Impact factor: 4.929

4.  Expression of BAG-1 and PARP-1 in precursor lesions and invasive cervical cancer associated with human papillomavirus (HPV).

Authors:  Marcela Kazue Hassumi-Fukasawa; Fabiana Alves Miranda-Camargo; Bruna Riedo Zanetti; Denise Faria Galano; Alfredo Ribeiro-Silva; Edson Garcia Soares
Journal:  Pathol Oncol Res       Date:  2012-03-28       Impact factor: 3.201

5.  Expressions of the anti-apoptotic genes Bag-1 and Bcl-2 in colon cancer and their relationship.

Authors:  Nianfeng Sun; Qingyi Meng; Ailing Tian
Journal:  Am J Surg       Date:  2010-04-20       Impact factor: 2.565

Review 6.  BAG-1, an anti-apoptotic tumour marker.

Authors:  Shou-Ching Tang
Journal:  IUBMB Life       Date:  2002-02       Impact factor: 3.885

7.  BAG-1 is up-regulated in colorectal tumour progression and promotes colorectal tumour cell survival through increased NF-kappaB activity.

Authors:  Nadine K Clemo; Tracey J Collard; Samantha L Southern; Kieron D Edwards; Moganaden Moorghen; Graham Packham; Angela Hague; Christos Paraskeva; Ann C Williams
Journal:  Carcinogenesis       Date:  2008-01-19       Impact factor: 4.944

8.  Oxidative stress-regulated lentiviral TK/GCV gene therapy for lung cancer treatment.

Authors:  Hanna M Leinonen; Anna-Kaisa Ruotsalainen; Ann-Marie Määttä; Heidi M Laitinen; Suvi M Kuosmanen; Emilia Kansanen; Jere T Pikkarainen; Jari P Lappalainen; Haritha Samaranayake; Hanna P Lesch; Minna U Kaikkonen; Seppo Ylä-Herttuala; Anna-Liisa Levonen
Journal:  Cancer Res       Date:  2012-10-04       Impact factor: 12.701

9.  Expression of BAG-1 protein correlates with aggressive behavior of prostate cancers.

Authors:  Maryla Krajewska; Bruce C Turner; Ahmed Shabaik; Stan Krajewski; John C Reed
Journal:  Prostate       Date:  2006-06-01       Impact factor: 4.104

10.  An online gene expression assay for determining adjuvant therapy eligibility in patients with stage 2 or 3 colon cancer.

Authors:  R K Van Laar
Journal:  Br J Cancer       Date:  2010-11-30       Impact factor: 7.640

View more
  3 in total

1.  Polyamidoamine dendrimer liposome-mediated survivin antisense oligonucleotide inhibits hepatic cancer cell proliferation by inducing apoptosis.

Authors:  Shuai Han; Zhai Cai; Liang Peng; Zhou Li; Hua-Bin Zhou; Xiu-Qin Li; Su-Zhen Fang; Zong-Hai Huang; Da-Xiang Cui
Journal:  Tumour Biol       Date:  2014-02-03

2.  Silencing Bag-1 gene via magnetic gold nanoparticle-delivered siRNA plasmid for colorectal cancer therapy in vivo and in vitro.

Authors:  Wenbai Huang; Zhan'ao Liu; Guanzhou Zhou; Jianmin Ling; Ailing Tian; Nianfeng Sun
Journal:  Tumour Biol       Date:  2016-02-04

3.  Expression and role of BAG-1 in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps.

Authors:  Dong Lin; Hai Lin; Xisheng Xiong
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.